Fasting can initially increase chemotherapy sensitivity in patients with established tumors but may eventually lead to more aggressive, metastatic, and treatment-resistant tumors. — Whalespan
Fasting can initially increase chemotherapy sensitivity in patients with established tumors but may eventually lead to more aggressive, metastatic, and treatment-resistant tumors.
⚠ High risk
We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
✕NOTSUPPORTED
⚠
High-risk intervention — consult a physician before acting.Drug-drug interactions, dose-dependence, and screening contraindications apply.
“in people with established tumors yes it does make the tumors more sensitive initially to chemotherapy but if the fasting continues eventually the tumors become very very aggressive stop responding to chemotherapy metastasize and invariably kill the patient so I think that's one reason why even mainstream oncologist they will tell you do not fast okay chemotherapy or radiotherapy do not fast eat your things”